Bioengineering PhD alumni Nick Fawzi and Sapun Parekh started a conversation about something completely different and ended up with a grant from the Human Frontier Science Program to study membraneless organelles.
Professor Amy Herr and her lab are highlighted in this Nature Methods Technology Feature, exploring new ways to for researchers to share designs, devices and experience.
Professors Sanjay Kumar and Kevin Healy, in collaboration with Professor of Nutritional Sciences and Toxicology Andreas Stahl, have discovered that the same kind of fat cells that help newborn babies regulate their body temperature could be a target for weight-loss drugs in adults.
BioE startup GenEdit is featured in Wired as the first company devoted solely to Crispr delivery.
Professor John Dueber’s lab has advanced two steps closer to cleaning up the dirty production of indigo dyes. Using synthetic biology they have done away with the wasteful chemical synthesis of indigo, and removed the damaging bleaching stage that converts indigo to leucoindigo.
Researchers led by Professor David Schaffer have for the first time used CRISPR-Cas9 gene editing to disable a defective gene that causes amyotrophic lateral sclerosis, or Lou Gehrig’s disease, in mice, extending their lifespan by 25 percent.
Bioengineering and EECS professor Steven Conolly is building a new kind of medical diagnostic technology called magnetic particle imaging (MPI).
The Open Philanthropy Project awarded a grant of $5 million over five years to support research on the basic biology of aging-related diseases and impairments, led by Dr. Irina Conboy.
In a paper published in the New England Journal of Medicine, Fletcher Lab describes how the LoaScope, a modification their Cellscope, can provide fast and effective testing for Loa loa parasites in the blood. Using the LoaScope to analyze the blood of volunteers from villages in Cameroon, doctors were able to successfully treat more than 15,000 patients with ivermectin without serious complications.